Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"Sitaxsentan"”.

  1. Podocyte repair and recovery in kidney disease

    … drug, the endothelin receptor A antagonist sitaxsentan was tested alone and in combination with captopril. RESULTS: Captopril reduced proteinuria and ameliorated scarring, with matrix accumulation and glomerulosclerosis falling almost to baseline. Podocyte counts were reduced after toxin …

    edinburgh Repository record for Podocyte repair and recovery in kidney disease (opens in a new tab)

  2. Endothelin‐1 antagonism in glomerulonephritis

    … effect of selective ETAR antagonism using Sitaxsentan in a rat model of GN. ETAR blockade reduced blood pressure and importantly reduced glomerular inflammation as assessed by glomerular macrophage (Mϕ) infiltration. Further, we aimed to demonstrate that Mϕ, key mediators of inflammation …

    edinburgh Repository record for Endothelin‐1 antagonism in glomerulonephritis (opens in a new tab)

  3. Modification of cardiovascular and renal risk factors using antagonists of the endothelin system

    … AS. In the next study I was able to prove that sitaxsentan, a selective oral ETA antagonist, did not cause functional blockade of the ETB receptor in man. This was the first study of its kind to confirm that a “selective” endothelin antagonist truly is selective in vivo: a finding that will …

    edinburgh Repository record for Modification of cardiovascular and renal risk factors using antagonists of the endothelin system (opens in a new tab)